These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10401166)

  • 1. Cost effectiveness of Streetworks' needle exchange program of Edmonton.
    Jacobs P; Calder P; Taylor M; Houston S; Saunders LD; Albert T
    Can J Public Health; 1999; 90(3):168-71. PubMed ID: 10401166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of syringe exchange as an HIV prevention strategy.
    Laufer FN
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):273-8. PubMed ID: 11694836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needle exchange programs: an economic evaluation of a local experience.
    Gold M; Gafni A; Nelligan P; Millson P
    CMAJ; 1997 Aug; 157(3):255-62. PubMed ID: 9269195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of SEPs.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151-2. PubMed ID: 11361923
    [No Abstract]   [Full Text] [Related]  

  • 6. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic evaluation of needle and syringe exchange in two provinces of Southwest China].
    Xue H; Hu Y; Sun J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):291-5. PubMed ID: 24969453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.
    Peak A; Rana S; Maharjan SH; Jolley D; Crofts N
    AIDS; 1995 Sep; 9(9):1067-70. PubMed ID: 8527080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Needle exchange programs are a cost-effective preventative measure against HIV in Iceland].
    Eythórsson ES; Ásgeirsdóttir TL; Gottfređsson M
    Laeknabladid; 2014 Jul; 100(7-8):379-83. PubMed ID: 25125435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program.
    Harris ZK
    Health Econ; 2006 Feb; 15(2):147-58. PubMed ID: 16145716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringe exchange in Canada: good but not enough to stem the HIV tide.
    Hankins CA
    Subst Use Misuse; 1998 Apr; 33(5):1129-46. PubMed ID: 9596380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.
    Enns EA; Zaric GS; Strike CJ; Jairam JA; Kolla G; Bayoumi AM
    Addiction; 2016 Mar; 111(3):475-89. PubMed ID: 26616368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.
    Bruneau J; Lamothe F; Franco E; Lachance N; Désy M; Soto J; Vincelette J
    Am J Epidemiol; 1997 Dec; 146(12):994-1002. PubMed ID: 9420522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needle exchange: friend or foe.
    Nedjat-Shokouhi B
    Focus; 2002 Feb; 17(3):1-4. PubMed ID: 11968159
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
    Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
    Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle and syringe programs in Yunnan, China yield health and financial return.
    Zhang L; Yap L; Xun Z; Wu Z; Wilson DP
    BMC Public Health; 2011 Apr; 11():250. PubMed ID: 21507267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.
    Nguyen TQ; Weir BW; Des Jarlais DC; Pinkerton SD; Holtgrave DR
    AIDS Behav; 2014 Nov; 18(11):2144-55. PubMed ID: 24824043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Uyei J; Fiellin DA; Buchelli M; Rodriguez-Santana R; Braithwaite RS
    Lancet Public Health; 2017 Mar; 2(3):e133-e140. PubMed ID: 29253386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.